Recalls / Firms / Ascend Laboratories, LLC

Ascend Laboratories, LLC

41 FDA drug recalls on record.

Date	Class	Drug	Status
2025-09-19	Class II	Atorvastatin Calcium	Ongoing
2025-09-19	Class II	Atorvastatin Calcium	Ongoing
2025-09-19	Class II	Atorvastatin Calcium	Ongoing
2025-09-19	Class II	Atorvastatin Calcium	Ongoing
2025-08-28	Class II	Aripiprazole	Ongoing
2025-07-21	Class II	Amlodipine And Olmesartan Medoxomil	Ongoing
2025-07-09	Class II	Rizatriptan Benzoate	Ongoing
2025-07-09	Class II	Rizatriptan Benzoate	Ongoing
2025-05-23	Class II	Cephalexin	Ongoing
2025-05-23	Class II	Cephalexin	Ongoing
2024-12-12	Class II	Dabigatran Etexilate	Ongoing
2024-12-12	Class II	Dabigatran Etexilate	Ongoing
2024-09-03	Class II	Mycophenolic Acid	Ongoing
2024-01-16	Class II	Fosfomycin Tromethamine	Ongoing
2023-12-29	Class II	Ibuprofen And Famotidine	Ongoing
2023-07-18	Class III	Fosfomycin Tromethamine	Terminated
2023-07-11	Class II	Fingolimod	Ongoing
2023-03-17	Class II	Aripiprazole	Ongoing
2023-03-14	Class II	Dabigatran Etexilate	Ongoing
2023-03-14	Class II	Dabigatran Etexilate	Ongoing
2023-01-05	Class II	Metoprolol Succinate	Terminated
2023-01-05	Class II	Metoprolol Succinate	Terminated
2023-01-05	Class II	Metoprolol Succinate	Terminated
2022-12-28	Class II	Rasagiline	Terminated
2022-01-12	Class II	Metoprolol Succinate	Terminated
2021-12-21	Class II	Cefixime	Terminated
2021-11-03	Class II	Cefixime	Terminated
2021-04-29	Class III	Olmesartan Medoxomil	Terminated
2021-01-22	Class II	Cephalexin	Terminated
2021-01-22	Class II	Cephalexin	Terminated
2020-12-17	Class II	Cephalexin	Terminated
2020-12-17	Class II	Cephalexin	Terminated
2020-11-24	Class II	Tizanidine	Terminated
2020-11-23	Class II	Cephalexin	Terminated
2020-01-24	Class II	Olmesartan Medoxomil	Terminated
2020-01-22	Class III	Minocycline Hydrochloride	Terminated
2019-07-19	Class II	Atorvastatin Calcium Tablet USP 80 mg, a) 90 count (NDC 67877-0514-90) and b) 500 count (N	Terminated
2019-02-22	Class II	Tamsulosin Hydrochloride	Terminated
2018-11-14	Class II	Quetiapine	Terminated
2017-05-05	Class III	Amlodipine Besylate	Terminated
2016-11-02	Class II	Metformin Hydrochloride	Terminated